66 related articles for article (PubMed ID: 34606328)
1. Global quality of life and mortality risk in patients with cancer: a systematic review and meta-analysis.
Fukushima T; Suzuki K; Tanaka T; Okayama T; Inoue J; Morishita S; Nakano J
Qual Life Res; 2024 May; ():. PubMed ID: 38811448
[TBL] [Abstract][Full Text] [Related]
2. Quality-of-life outcomes and risk prediction for patients randomized to nivolumab plus ipilimumab vs nivolumab on LungMAP-S1400I.
Unger JM; Qian L; Redman MW; Tavernier SS; Minasian L; Sigal EV; Papadimitrakopoulou VA; Leblanc M; Cleeland CS; Dzingle SA; Summers TJ; Chao H; Madhusudhana S; Villaruz L; Crawford J; Gray JE; Kelly KL; Gandara DR; Bazhenova L; Herbst RS; Gettinger SN; Moinpour CM
J Natl Cancer Inst; 2023 Apr; 115(4):437-446. PubMed ID: 36625510
[TBL] [Abstract][Full Text] [Related]
3. Observational study to predict the efficacy and optimal duration of nivolumab treatment in patients with previously treated advanced or recurrent non-small cell lung cancer.
Goto Y; Yoh K; Kato T; Hosomi Y; Usui K; Fukui T; Hirano K; Tanaka H; Taguri M; Kunitoh H
Jpn J Clin Oncol; 2023 Jan; 53(2):153-160. PubMed ID: 36300307
[TBL] [Abstract][Full Text] [Related]
4. Timely Palliative Care: Personalizing the Process of Referral.
Hui D; Heung Y; Bruera E
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205793
[TBL] [Abstract][Full Text] [Related]
5. Gefitinib for advanced non-small cell lung cancer.
Sim EH; Yang IA; Wood-Baker R; Bowman RV; Fong KM
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD006847. PubMed ID: 29336009
[TBL] [Abstract][Full Text] [Related]
6. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
Greenhalgh J; Dwan K; Boland A; Bates V; Vecchio F; Dundar Y; Jain P; Green JA
Cochrane Database Syst Rev; 2016 May; (5):CD010383. PubMed ID: 27223332
[TBL] [Abstract][Full Text] [Related]
7. Association Between Health-Related Quality of Life and Progression-Free Survival in Patients With Advanced Cancer: A Secondary Analysis of SWOG Clinical Trials.
Hui D; Darke AK; Guthrie KA; Subbiah IM; Unger JM; Hershman DL; Krouse RS; Bakitas M; O'Rourke MA
JCO Oncol Pract; 2022 Apr; 18(4):e442-e451. PubMed ID: 34606328
[TBL] [Abstract][Full Text] [Related]
8. Quality of life is significantly associated with survival in women with advanced epithelial ovarian cancer: An ancillary data analysis of the NRG Oncology/Gynecologic Oncology Group (GOG-0218) study.
Phippen NT; Secord AA; Wolf S; Samsa G; Davidson B; Abernethy AP; Cella D; Havrilesky LJ; Burger RA; Monk BJ; Leath CA
Gynecol Oncol; 2017 Oct; 147(1):98-103. PubMed ID: 28743369
[TBL] [Abstract][Full Text] [Related]
9. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
[TBL] [Abstract][Full Text] [Related]
10. Prognostic effects of health-related quality of life at baseline and early change in health-related quality of life on response to treatment and survival in patients with advanced lung cancer: a prospective observational study in China.
Liu J; Ma Y; Gao R; Liu X; Wang Y; Yu J; Zhan J; Huang Y; Qin H; Zhang L
BMJ Open; 2022 Feb; 12(2):e047611. PubMed ID: 35165103
[TBL] [Abstract][Full Text] [Related]
11. Quality of life assessment in advanced non-small-cell lung cancer patients undergoing an accelerated radiotherapy regimen: report of ECOG study 4593. Eastern Cooperative Oncology Group.
Auchter RM; Scholtens D; Adak S; Wagner H; Cella DF; Mehta MP
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1199-206. PubMed ID: 11483329
[TBL] [Abstract][Full Text] [Related]
12. What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) Questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) Study 5592.
Cella D; Eton DT; Fairclough DL; Bonomi P; Heyes AE; Silberman C; Wolf MK; Johnson DH
J Clin Epidemiol; 2002 Mar; 55(3):285-95. PubMed ID: 11864800
[TBL] [Abstract][Full Text] [Related]
13. Health-related Quality of Life in Patients with Advanced Prostate Cancer: A Systematic Review.
Kretschmer A; Ploussard G; Heidegger I; Tsaur I; Borgmann H; Surcel C; Mathieu R; de Visschere P; Valerio M; van den Bergh RCN; Marra G; Thibault C; Ost P; Gandaglia G; Tilki D;
Eur Urol Focus; 2021 Jul; 7(4):742-751. PubMed ID: 32089495
[TBL] [Abstract][Full Text] [Related]
14. Models of Palliative Care Delivery for Patients With Cancer.
Hui D; Bruera E
J Clin Oncol; 2020 Mar; 38(9):852-865. PubMed ID: 32023157
[TBL] [Abstract][Full Text] [Related]
15. Association of baseline symptom burden with efficacy outcomes: Exploratory analysis from the randomized phase III REVEL study in advanced non-small-cell lung cancer.
Pérol M; Winfree KB; Cuyun Carter G; Lin Cui Z; Bowman L; Garon EB
Lung Cancer; 2019 May; 131():6-13. PubMed ID: 31027699
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
